|Outsourcing Outlook Eric LangerCMOs Plan for Capacity Expansions|
|Regulatory Watch Jill Wechsler Vaccine Development and Production Challenges Manufacturers|
|European Regulatory Watch Sean Milmo Europe Strives for a More Efficient Generic-Drug Approval Framework|
Is there enough talent to go around?
The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.
Novasep has entered into an agreement with Celladon to provide scale-up and pre-validation studies for the drug substance for MYDICAR.